WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Stock Forecast, Predictions & Price Target

Analyst price target for NKTR

Based on 1 analyst offering 12 month price targets for Nektar Therapeutics.
Min Forecast
$1.00+12.99%
Avg Forecast
$1.00+12.99%
Max Forecast
$1.00+12.99%

Should I buy or sell NKTR stock?

Based on 1 analyst offering ratings for Nektar Therapeutics.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NKTR stock forecasts and price targets.

NKTR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-06

1 of 1

Forecast return on equity

Is NKTR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is NKTR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NKTR revenue forecast

What is NKTR's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$72.1M-19.96%
Avg 2 year Forecast
$65.6M-27.17%
Avg 3 year Forecast
$60.7M-32.68%
NKTR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NKTR revenue growth forecast

How is NKTR forecast to perform vs Biotechnology companies and vs the US market?
Company
-12.51%
Industry
38.94%
Market
10.52%
NKTR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NKTR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NKTR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NKTR$0.89$1.00+12.99%Hold
IVA$3.82$19.67+414.84%Strong Buy
GNLX$6.02$32.50+439.87%Buy
BCAB$3.46$9.50+174.57%Buy
KPTI$1.48$5.33+260.34%Strong Buy

Nektar Therapeutics Stock Forecast FAQ

Is Nektar Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NKTR) stock is to Hold NKTR stock.

Out of 1 analyst, 0 (0%) are recommending NKTR as a Strong Buy, 0 (0%) are recommending NKTR as a Buy, 1 (100%) are recommending NKTR as a Hold, 0 (0%) are recommending NKTR as a Sell, and 0 (0%) are recommending NKTR as a Strong Sell.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.

What is NKTR's revenue growth forecast for 2024-2026?

(NASDAQ: NKTR) Nektar Therapeutics's forecast annual revenue growth rate of -12.51% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Nektar Therapeutics's revenue in 2024 is $90,122,000.On average, 5 Wall Street analysts forecast NKTR's revenue for 2024 to be $13,245,454,847, with the lowest NKTR revenue forecast at $4,076,315,537, and the highest NKTR revenue forecast at $17,015,863,101. On average, 5 Wall Street analysts forecast NKTR's revenue for 2025 to be $12,051,204,565, with the lowest NKTR revenue forecast at $4,204,848,009, and the highest NKTR revenue forecast at $17,015,863,101.

In 2026, NKTR is forecast to generate $11,140,460,193 in revenue, with the lowest revenue forecast at $4,333,380,481 and the highest revenue forecast at $17,941,296,899.

What is NKTR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NKTR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NKTR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NKTR price target, the average NKTR price target is $1.00, with the highest NKTR stock price forecast at $1.00 and the lowest NKTR stock price forecast at $1.00.

The Wall Street analyst predicted that Nektar Therapeutics's share price could reach $1.00 by Mar 6, 2025. The average Nektar Therapeutics stock price prediction forecasts a potential upside of 12.99% from the current NKTR share price of $0.89.

What is NKTR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NKTR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.